Nano-X Imaging Ltd. (NNOX) Q2 2022 Earnings Call Transcript
NNOX earnings call for the period ending June 30, 2022.
Stay updated with breaking news from Bio Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NNOX earnings call for the period ending June 30, 2022.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
V-Bio Ventures raises EUR 110 million for its second fund and expands teamGhent, Belgium, 31 March 2022 – V-Bio Ventures announced the final closing of its second fund, V-Bio Fund 2, having raised EUR 110 million euro and exceeding its target of EUR 100 million.Together with their first fund, V-Bio Fund 1, V-B...
/PRNewswire/ -- DeciBio Consulting, LLC, a precision medicine-focused strategy consulting and market intelligence firm, has launched DeciBio Ventures. This...
Additional EUR 32.5 million will support clinical readiness and accelerate lead immuno-virotherapy candidates toward clinical proof-of-concept Abalos Therapeutics announced today an extension